Analysis of the European Cardiac Biomarkers Diagnostics Market

High Prevalence of Heart Disease Propels Market Growth

USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

The increase in demand for high quality cardiac testing has made diagnostic companies to diversify their products and shift towards genetic biomarkers and advanced point-of-care diagnostics. This research service analyses the cardiac biomarkers diagnostics market in Europe, particularly, for Acute Myocardial Infarction (AMI) and Congestive Heart Failure (CHF). It provides competitive landscape analysis, market share analysis, revenue forecasts, market engineering measurements, key trends and product profiles, along with strategic recommendations. The regional market analysis includes the United Kingdom, Germany, France, Italy, Spain, Benelux and Scandinavia. The period covered in the study is 2008-2018.

Table of Contents

Analysis of the European Cardiac Biomarkers Diagnostics Market, European Cardiac Biomarkers Diagnostics MarketExecutive Summary of the European Cardiac Diagnostics MarketTitle Slide Contact Details and Table of contentsExecutive SummaryExecutive Summary—Market Engineering Measurements Executive Summary—CEO’s Perspective Market OverviewMarket Overview—DefinitionsMarket Overview—Key Questions This Study Will AnswerMarket Overview—Research Aim and ScopeMarket Overview—SegmentationExternal Challenges: Drivers and Restraints—Total Cardiac Biomarkers Diagnostics MarketDrivers and RestraintsDrivers ExplainedRestraints ExplainedImpact Mapping of Drivers and RestraintsForecast and Trends—Total Cardiac Biomarkers Diagnostics MarketMarket Engineering MeasurementsForecast AssumptionsTotal Cardiac Biomarkers Diagnostics Market Revenue ForecastRevenue Forecast DiscussionMarket Share and Competitive Analysis—Total Cardiac Biomarkers Diagnostics MarketCompetitive Analysis—Market ShareMarket Share AnalysisCompetitive EnvironmentCompetitive Landscape AnalysisCompetitive Analysis—Selected Key Market ParticipantsAMI Biomarkers Diagnostics Segment BreakdownMarket OverviewAMI Biomarkers Diagnostics Segment—Market Engineering MeasurementsAMI Biomarkers Diagnostics Segment Revenue ForecastRevenue Forecast DiscussionAMI Biomarkers Diagnostics Segment—Market Metrics AnalysisCompetitive Analysis—Market ShareMarket Share AnalysisCompetitive EnvironmentCompetitive Factors and AssessmentProduct ProfilesCHF Biomarkers Diagnostics Segment BreakdownMarket OverviewCHF Marker Diagnostics Segment—Market Engineering MeasurementsCHF Biomarkers Diagnostics Segment Revenue ForecastRevenue Forecast DiscussionCHF Biomarkers Diagnostics Segment—Market Metrics AnalysisCompetitive Analysis—Market ShareMarket Share AnalysisCompetitive EnvironmentCompetitive Factors and AssessmentProduct ProfilesRegional AnalysisRegional OverviewThe United Kingdom BreakdownThe United Kingdom Market—IntroductionThe United Kingdom Market—Market Engineering MeasurementsThe United Kingdom Market—Revenue ForecastThe United Kingdom Market—Revenue Forecast DiscussionGermany BreakdownGermany Market—IntroductionGermany Market—Market Engineering MeasurementsGermany Market—Revenue ForecastGermany Market—Revenue Forecast DiscussionFrance BreakdownFrance Market—IntroductionFrance Market—Market Engineering MeasurementsFrance Market—Revenue ForecastFrance Market—Revenue Forecast DiscussionItaly BreakdownItaly Market—IntroductionItaly Market—Market Engineering MeasurementsItaly Market—Revenue ForecastItaly Market—Revenue Forecast DiscussionSpain BreakdownSpain Market—IntroductionSpain Market—Market Engineering MeasurementsSpain Market—Revenue ForecastSpain Market—Revenue Forecast DiscussionThe Benelux BreakdownThe Benelux Market—IntroductionThe Benelux Market—Market Engineering MeasurementsThe Benelux Market—Revenue ForecastThe Benelux Market—Revenue Forecast DiscussionScandinavia BreakdownScandinavia Market—IntroductionScandinavia Market—Market Engineering MeasurementsScandinavia Market—Revenue ForecastScandinavia Market—Revenue Forecast DiscussionConclusions and Strategic RecommendationsConclusionsStrategic RecommendationsThe Last Word (Conclusions and Implications)The Last Word—Three Big PredictionsLegal DisclaimerAppendixMarket Engineering MethodologyOther Related StudiesPrevalence of Cardiovascular DiseasesCoronary Heart DiseaseNew Cases of Heart Attack




Related Research

Release Date : 17-May-18

Region : Europe

Release Date : 16-May-18

Region : Europe

Release Date : 27-Apr-18

Region : Europe

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.